ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 27445 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 27445; 2) Community: the network communities that were significantly associated with the response to NSC 27445; 3) Molecule: the relationships between components within communities and NSC 27445; 4) MDR: the compounds that were significantly associated with the NSC 27445.

NSC Compound Enrichment Correlation
NSC 650262 Null 0.00265989583551648 0.17110151
NSC 652175 2-Pyrazolin-5-one, 1-[(2-hydroxyphenyl)carbonyl]- 3-methyl-4-[(4-nitrophenyl)methylene]- 0.00265989583551648 0.57074418
NSC 678401 Glycine, N-[N-[[(4-methoxyphenyl)azo]carbonyl]-L-leucyl]-, dicyclohexylamine salt 0.00265989583551648 0.11179395
NSC 294961 5-Bromo-3-(2-oxo-2-phenylethylidene)- 1,3-dihydroindol-2-one 0.00334162892839391 -0.047745839
NSC 114567 EUPACHLORIN 0.00334162892839397 -0.12748288
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.00337662564965909 0.094804324
NSC 313681 Oxiperomide(USAN) 0.00337662564965909 0.29093922
NSC 677784 Null 0.00337662564965909 0.11057415
NSC 681632 Camptothecin Derivative 0.00337662564965909 0.26632767
NSC 752270 2,7-Bis-[3-(2-chloro-benzylamino)-propyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate 0.00337662564965909 -0.077092861
Total:43  Current:3    [First] [Prev] [Next] [Last]